EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Rapid and Slow Progressors Toward β-Cell Depletion and Their Predictors in Type 1 Diabetes: Prospective Longitudinal Study in Japanese Type 1 Diabetes (TIDE-J)

Shinsuke Noso iD, Daisuke Chujo iD, Akihisa Imagawa iD, Eiji Kawasaki iD, Takuya Awata iD, Kazuki Yasuda iD, Norio Abiru, Noriko Kodani iD, Yoichi Oikawa iD, Tomoyasu Fukui iD, Takeshi Katsuki, Junji Kozawa iD und 13 weitere

Diabetes Care · 2025

DOI: 10.2337/dc25-0579 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Diabetes Care, 2025. Verfasst von Shinsuke Noso und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin-Secreting Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Center for Global Health and Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE This study aimed to investigate the progression of β-cell dysfunction and its predictors in Japanese patients with type 1 diabetes, using data from the nationwide, multicenter, prospective longitudinal Japanese Type 1 Diabetes Database Study (TIDE-J). RESEARCH DESIGN AND METHODS TIDE-J enrolled 314 Japanese individuals with type 1 diabetes, including 165 with acute-onset, 105 with slowly progressive, and 44 with fulminant type 1 diabetes. Clinical data, including C-peptide levels, glycemic control, and autoantibody status, were collected annually for up to 14 years. HLA genotypes were analyzed at study entry. The time to insulin depletion was analyzed using survival curves and Cox proportional hazards models to determine predictive factors. RESULTS The rate of undetectable C-peptide varied significantly among subtypes. At 5 years after onset, 43.1% (n = 55) of patients with acute-onset, 9.1% (n = 7) with slowly progressive, and 93.2% (n = 38) with fulminant type 1 diabetes reached undetectable C-peptide. Even within acute-onset type 1 diabetes, a marked interindividual variation was observed in the progression toward β-cell depletion. HLA genotypes influenced progression rates as follows: DRB1*04:05-DQB1*04:01/DRB1*04:05-DQB1*04:01 (DR4/DR4) carriers exhibited slower β-cell depletion, whereas DR4/DRB1*08:02-DQB1*03:02 (i.e., DR4/DR8) and DR4/DRB1*09:01-DQB1*03:03 (i.e., DR4/DR9) were associated with a rapid progression. For slowly progressive type 1 diabetes, low BMI, GAD antibody positivity, and absence of the DRB1*15:01-DQB1*06:02 or DRB1*15:02-DQB1*06:01 (i.e., DR2) haplotype were predictive of progression to insulin dependence. CONCLUSIONS This study elucidates the heterogeneity in β-cell dysfunction among Japanese individuals with type 1 diabetes and identifies genetic and clinical predictors of disease progression. These findings provide insights for individualized management strategies and future therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Insulin-Secreting CellsAdolescentAdultChildChild, PreschoolFemaleHumansMaleYoung AdultAutoantibodiesC-PeptideDisease ProgressionGenotypeJapanLongitudinal StudiesProspective StudiesEast Asian People

Substanzen

AutoantibodiesC-Peptide

Autor:innen und Institutionen

  • Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Department of Diabetes, Metabolism, and Endocrinology, International University of Health and Welfare, Ichikawa, Japan.
  • Department of Internal Medicine (I), Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Diabetes, Thyroid and Endocrine Center, Shin-Koga Hospital, Kurume, Japan.
  • Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Department of Diabetes, Endocrinology, and Metabolism, Kyorin University, Mitaka, Japan.

ORCID-Profile: Shinsuke Noso, Daisuke Chujo, Akihisa Imagawa, Eiji Kawasaki, Takuya Awata, Kazuki Yasuda, Noriko Kodani, Yoichi Oikawa, Tomoyasu Fukui, Junji Kozawa, Haruhiko Osawa, Hisafumi Yasuda, Norikazu Maeda, Akira Shimada, Tetsuro Kobayashi, Toshiaki Hanafusa, Hiroshi Kajio, Hiroshi Ikegami

Förderung

  • National Center for Global Health and Medicine

Zitieren

APA

Noso, S., Chujo, D., Imagawa, A., Kawasaki, E., Awata, T., Yasuda, K., Abiru, N., Kodani, N., Oikawa, Y., Fukui, T., Katsuki, T., Kozawa, J., Nagasawa, K., Osawa, H., Takahashi, K., Tsuchiya, K., Shimoda, M., Yasuda, H., Maeda, N., …, & Japanese Type 1 Diabetes Database Study (TIDE-J) Genetics (2025). Rapid and Slow Progressors Toward β-Cell Depletion and Their Predictors in Type 1 Diabetes: Prospective Longitudinal Study in Japanese Type 1 Diabetes (TIDE-J). Diabetes Care. https://doi.org/10.2337/dc25-0579

Vancouver

Noso S, Chujo D, Imagawa A, Kawasaki E, Awata T, Yasuda K, et al. Rapid and Slow Progressors Toward β-Cell Depletion and Their Predictors in Type 1 Diabetes: Prospective Longitudinal Study in Japanese Type 1 Diabetes (TIDE-J). Diabetes Care. 2025. doi:10.2337/dc25-0579

BibTeX
@article{Noso2025,
  author = {Noso, Shinsuke and Chujo, Daisuke and Imagawa, Akihisa and Kawasaki, Eiji and Awata, Takuya and Yasuda, Kazuki and Abiru, Norio and Kodani, Noriko and Oikawa, Yoichi and Fukui, Tomoyasu and Katsuki, Takeshi and Kozawa, Junji and Nagasawa, Kan and Osawa, Haruhiko and Takahashi, Kazuma and Tsuchiya, Kyoichiro and Shimoda, Masayuki and Yasuda, Hisafumi and Maeda, Norikazu and Shimada, Akira and Kobayashi, Tetsuro and Hanafusa, Toshiaki and Kajio, Hiroshi and Ikegami, Hiroshi and Japanese Type 1 Diabetes Database Study (TIDE-J) Genetics, Japanese Type 1 Diabetes Database Study (TIDE-J) Genetics},
  title = {Rapid and Slow Progressors Toward β-Cell Depletion and Their Predictors in Type 1 Diabetes: Prospective Longitudinal Study in Japanese Type 1 Diabetes (TIDE-J)},
  journal = {Diabetes Care},
  year = {2025},
  doi = {10.2337/dc25-0579}
}
Kostenlos starten →